We are live on ! Find out more
ONCS

OncoSec Medical Incorporated
ONCS

Delisted

ONCS was delisted on the 23rd of June, 2023.

Back to rankings

12 hedge funds and large institutions have $665K invested in OncoSec Medical Incorporated in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

151% more capital invested

Capital invested by funds: $265K → $665K (+$400K)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

29% less funds holding

Funds holding: 17 → 12 (-5)

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

Holders
12
Holders Change
-5
Holders Change %
-29.41%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
2
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FIA
FNY Investment Advisers
New York
+$210K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$114K
3
LPL Financial
LPL Financial
California
+$34.5K
4
Wells Fargo
Wells Fargo
California
+$3.82K
5
BlackRock
BlackRock
New York
+$2

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$41K
2
Two Sigma Investments
Two Sigma Investments
New York
-$35.5K
3
VF
Virtu Financial
New York
-$22K
4
TSS
Two Sigma Securities
New York
-$20.7K
5
UBS Group
UBS Group
Switzerland
-$13.9K

ONCS Hedge Fund Activity: Q1 2023 in Review

12 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q1 2023, worth a combined $665K — up 151% from $265K a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of ONCS and 3 opened new positions — a net loss of 5 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was FNY Investment Advisers, opening a new position worth an estimated $210K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $41K sold.

  • 12 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q1 2023, down from 17 in Q4 2022.
  • Funds reported $665K of OncoSec Medical Incorporated stock for Q1 2023, up 151% quarter-over-quarter.
  • 3 funds opened new OncoSec Medical Incorporated positions in Q1 2023 and 8 closed out, a net change of -5 holders.
  • The largest OncoSec Medical Incorporated buyer in Q1 2023 was FNY Investment Advisers, an estimated $210K added.
  • The largest OncoSec Medical Incorporated seller in Q1 2023 was Renaissance Technologies, an estimated $41K sold.

Based on aggregated 13F filings for Q1 2023.